Fabesetron - CAS 129300-27-2

Fabesetron (FK1052) is an orally active compound that acts as a dual antagonist of 5-HT3 and 5-HT4 receptors, demonstrating efficacy in managing emesis induced by cancer chemotherapy and showing potential for addressing both acute and delayed symptoms.

5-HT Receptor, Others

Neuroscience, GPCR/G Protein, Others

129271

C18H19N3O

293.37

Cc1nc[nH]c1C[C@H]1CCc2c(C)c3ccccc3n2C1=O

-20°C

Ice Packs

Small Compound